Public aggregate: WITHHELD pending evidence-backed Monte Carlo re-estimation and row-level portfolio tie-out.
URL note: the /evidence/73-7t/ address is historical. It remains as a stable evidence route while the replacement estimate is prepared.
Precision note: the ranked aggregate remains withheld while the 61 studied rows undergo evidence-backed re-estimation. WMD and Gene Drives lack a commercial revenue denominator. Sovereign Debt has a reported candidate under review; its source, denominator, period, and overlap receipts are incomplete. The row-level source tie-out, overlap ledger, dependence model, and rerun receipt are release requirements.
This page gives the verification path for the aggregate claim. It states the release status, boundary, and audit route for the domain rows and source manuscript.
The underlying study record is the aggregate System Asset Pricing Model welfare-destruction manuscript in the Study Archive. This static evidence page exists so crawlers and public readers do not have to rely on the client-rendered study interface to verify the headline.
WITHHELD
WORKING ESTIMATE
61
STUDIED ROWS
withheld pending rank/aggregate receipt
SYSTEM-WELFARE-ADJUSTED GDP RANKED ROWS
annual industry revenue
WELFARE-BETA DENOMINATOR
working paper
STATUS
STATUS
Working-paper aggregate; external review open.
STUDY RECORD
The source manuscript is the aggregate System Asset Pricing Model welfare-destruction record in the Study Archive.
SCOPE
61 studied System Asset Pricing Model domains are visible in the table. The System-Welfare-Adjusted GDP ranked total is withheld pending rank/aggregate receipt; outside-frame rows remain visible for audit and enter the ranked total only after the rank/aggregate receipt passes.
NUMERATOR
Annual system-welfare loss, written as ΔW (delta W), estimated for each domain.
DENOMINATOR
Annual industry revenue, written as Π (capital pi). Profit, earnings, market capitalization, or transaction volume are not valid welfare-beta denominators unless explicitly flagged as a noncanonical draft defect.
AGGREGATE RULE
The ranked aggregate remains withheld until approved domain rows reproduce it from signed receipts. The full 61-row audit keeps outside-frame rows separate from revenue-proportional βW rows.
OUTSIDE-ΒW ROWS
WMD has no commercial revenue base. Gene Drives is pre-revenue and has no commercial market. Sovereign Debt has a reported matched-flow candidate under source, denominator, period, and overlap review. No sovereign-debt value is released to the ranked total.
BOUNDARY ROWS
Boundary/comparator records remain visible because their welfare beta is below threshold, denominator treatment is limited, or the row is mainly comparative. They remain part of the 61 studied-domain corpus.
PEER-REVIEW STATUS
The estimate is public working-paper material, not settled economic canon.
HOW TO VERIFY
Start with the 61-domain table, where each visible row exposes welfare beta (βW), annual industry revenue (Π, capital pi), annual system-welfare loss (ΔW, delta W), and the status of any model-based p05–p95 interval, together with its evidence route. Then read the source manuscript record for the aggregate. Use the welfare-beta methodology manual for denominator discipline, canonical versus provisional row status, and the point-estimate caveat.
SOURCE MANUSCRIPT SUMMARY
The aggregate study record is the working-paper manuscript for the System Asset Pricing Model portfolio estimate. The public ranked result remains withheld until the admitted rank/aggregate receipt identifies the ranked rows and clears denominator, channel, overlap, dependence, and rerun checks. Outside-frame rows remain visible for audit, with no unreconciled numerical values released.